|
|
Volumn 23, Issue 5, 2015, Pages 791-792
|
|
The ups and downs of clinical translation of new technologies: Déjà vu all over again
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANIVAMERSEN;
APTAMER;
BLOOD CLOTTING FACTOR 9A;
PEGAPTANIB;
PEGNIVACOGIN;
ADAPTIVE IMMUNITY;
AGE RELATED MACULAR DEGENERATION;
BASIC RESEARCH;
BINDING AFFINITY;
BIOTECHNOLOGY;
CLINICAL TRIAL (TOPIC);
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
EDITORIAL;
GENE THERAPY;
HUMAN;
IMMUNOREACTIVITY;
IMMUNOSTIMULATION;
INCIDENCE;
MEDICAL LITERATURE;
MEDICAL TECHNOLOGY;
NONHUMAN;
OLIGONUCLEOTIDE THERAPY;
PUBLICATION;
RNA INTERFERENCE;
TRANSLATIONAL RESEARCH;
UNITED STATES;
TRENDS;
BIOTECHNOLOGY;
GENETIC THERAPY;
HUMANS;
TRANSLATIONAL MEDICAL RESEARCH;
|
|
EID: 84928945537
PISSN: 15250016
EISSN: 15250024
Source Type: Journal
DOI: 10.1038/mt.2015.51 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|
